Pembroke Real Estate has signed Così, the national fast casual restaurant chain, as a new retail tenant at Seaport Place along with Blue State Coffee and Blo Blow Dry Bar. Così will lease 2,755 s/f at Seaport East at the corner of Congress St. and Seaport Lane. Blue State Coffee will be located in 640 s/f on the ground floor of Seaport West and Blo Blow Dry Bar will lease 1,197 s/f on the ground floor of the Seaport West podium building. All three are expected to open for business by year-end.
Seaport East is a 502,000 s/f, 16-story office tower, and Seaport West is a 575,000 s/f, 17-story office tower. Both LEED Silver certified, class A office towers were developed by Pembroke Real Estate and are part of Seaport Place, Boston's only modern waterfront business center, which also includes the Seaport Hotel, Seaport World Trade Center, a variety of retail shops and two parks.
"Così, Blue State Coffee and Blo Blow Dry Bar will complement and diversify the retail options already available in the Seaport District," said David Lucey, vice president and head of U.S. operations, Pembroke Real Estate. "We are excited to see the development going on around us and these new retailers will help meet the needs of a continually growing population of workers, residents and tourists, as well as our tenants at Seaport Place."
The three leases follow the signing of Intarcia Therapeutics, who recently moved to the 11th floor of Seaport West. Intarcia is a late stage biopharmaceutical company committed to developing innovative therapies that merge medicine with novel delivery technology. It is currently in final trials for the approval of a breakthrough once-yearly diabetes medication.
Jonathan Martin of Colliers International represented Pembroke Real Estate in the transactions with Così, Blue State Coffee and Blo Blow Dry Bar. Così was represented by Joe Levanto of CRE Brokerage and Colliers represented Blo Blow Dry Bar and Blue State Coffee. Bill Anderson, Tim Bianchi and Deb Gould of Cushman & Wakefield represented Pembroke in the transaction with Intarcia Therapeutics, who was represented by Patrick Buckley and Jonathan Varholak of Richards Barry Joyce & Partners.